Searching... please wait. You've got 265 hits!
Acronym | Full Name | Score | Rating | Judge me | Search |
PE | pulmonary embolism | 398 | 4 | good bad | |
PE | phosphatidylethanolamine | 184 | 391 | good bad | |
PE | plasma exchange | 84 | 2 | good bad | |
PE | Pseudomonas exotoxin A | 24 | 3408 | good bad | |
PE | peritoneal exudate | 22 | 3555 | good bad | |
PE | phycoerythrin | 22 | 69 | good bad | |
PE | pulmonary emboli | 21 | 767 | good bad | |
PE | phosphatidylcholine (PC) and phosphatidylethanolamine | 19 | 7 | good bad | |
PE | plating efficiency | 18 | 5 | good bad | |
PE | pulmonary embolus | 14 | 8 | good bad | |
PE | physical education | 11 | 948 | good bad | |
PE | preeclampsia | 11 | 71 | good bad | |
PE | pigment epithelium | 11 | 6 | good bad | |
PE | plasma exchanges | 10 | 10791 | good bad | |
PE | physical examination | 10 | 6984 | good bad | |
PE | postexposure | 10 | 0 | good bad | |
PE | Pericardial effusion | 9 | 3581 | good bad | |
PE | pulmonary edema | 9 | 3281 | good bad | |
PE | pulmonary emphysema | 6 | 3595 | good bad | |
PE | pigmented ciliary epithelial | 5 | 740 | good bad | |
PE | persistent estrus | 5 | 716 | good bad | |
PE | physical exercise | 5 | 627 | good bad | |
PE | phosphatidyl-ethanolamine | 5 | 597 | good bad | |
PE | phosphorylethanolamine | 5 | 313 | good bad | |
PE | persistent estrous | 4 | 4239 | good bad | |
PE | phosphatidylserine (PS) and phosphatidylethanolamine | 4 | 3639 | good bad | |
PE | plating efficiencies | 4 | 2072 | good bad | |
PE | polychromatic erythrocytes | 4 | 73 | good bad | |
PE | pleural effusions | 4 | 4 | good bad | |
PE | premature ejaculation | 4 | 3 | good bad | |
PE | prolonged exposure in vivo | 4 | 2 | good bad | |
PE | penile erection | 4 | 1 | good bad | |
PE | penile erections | 4 | 0 | good bad | |
PE | promoter | 3 | 7318 | good bad | |
PE | post-exposure | 3 | 7188 | good bad | |
PE | phosphoethanolamine | 3 | 5544 | good bad | |
PE | perindopril | 3 | 3929 | good bad | |
PE | 2-phenylethylamine | 3 | 928 | good bad | |
PE | pancreatic elastase | 3 | 718 | good bad | |
PE | petroleum ether | 3 | 567 | good bad | |
PE | periventricular nucleus | 3 | 112 | good bad | |
PE | pharyngoesophageal | 3 | 61 | good bad | |
PE | prolonged exposure | 3 | 41 | good bad | |
PE | phacoemulsification | 3 | 10 | good bad | |
PE | progressive encephalopathy | 3 | 4 | good bad | |
PE | parasitized erythrocytes | 3 | 0 | good bad | |
PE | pre-eclampsia | 3 | -1 | good bad | |
PE | Pregnenolone | 3 | -2 | good bad | |
PE | pharmaceutical expenditure | 2 | 6553 | good bad | |
PE | pulmonary embolization | 2 | 5296 | good bad | |
PE | polychromatic erythrocytes (MPE) among polychromatic erythrocytes | 2 | 5105 | good bad | |
PE | pearl | 2 | 5086 | good bad | |
PE | psoriasis erythrodermica | 2 | 2823 | good bad | |
PE | penetration enhancers | 2 | 2275 | good bad | |
PE | protective efficacy | 2 | 1650 | good bad | |
PE | pulmonary thromboembolism | 2 | 1119 | good bad | |
PE | phosphatidylcholines (PC) and phosphatidylethanolamines | 2 | 885 | good bad | |
PE | protein extravasation | 2 | 882 | good bad | |
PE | Plasmodium falciparum-infected erythrocytes | 2 | 676 | good bad | |
PE | pineal extract | 2 | 471 | good bad | |
PE | Polyurethane (PU) and polyethylene | 2 | 453 | good bad | |
PE | platelet extract | 2 | 63 | good bad | |
PE | preeclamptic | 2 | 7 | good bad | |
PE | cisplatin-etoposide | 2 | 3 | good bad | |
PE | permeability | 2 | 3 | good bad | |
PE | phenylephrine hydrochloride | 2 | 1 | good bad | |
PE | Precedence Effect | 2 | 0 | good bad | |
PE | propylene oxide | 2 | -2 | good bad | |
PE | pre-mixed fluorescein isothiocyanate (FITC) and R-phycoerythrin | 1 | 17002 | good bad | |
PE | pyroglutamate | 1 | 12144 | good bad | |
PE | phase encoding | 1 | 9028 | good bad | |
PE | phosphatidylcholine (PC) and ethanolamine | 1 | 8739 | good bad | |
PE | PERA/Ei | 1 | 8520 | good bad | |
PE | polyethylene terephthalate (PET) and polyethylene | 1 | 8488 | good bad | |
PE | potentials | 1 | 8107 | good bad | |
PE | (R)-phycoerythrin | 1 | 8051 | good bad | |
PE | product and pro-enkephalin | 1 | 7912 | good bad | |
PE | physician's extender | 1 | 7812 | good bad | |
PE | presence of phosphatidylethanolamine | 1 | 7663 | good bad | |
PE | pars esophageal | 1 | 7540 | good bad | |
PE | patients with failed Kasai portoenterostomy | 1 | 7254 | good bad | |
PE | profiles in phosphatidylethanolamine | 1 | 7018 | good bad | |
PE | plus etoposide | 1 | 6849 | good bad | |
PE | proliferative effect | 1 | 6779 | good bad | |
PE | pseudoexfoliation | 1 | 6604 | good bad | |
PE | (GM-CSF)-Pseudomonas exotoxin | 1 | 6491 | good bad | |
PE | propidium iodide (PI) and R-phycoerythrin | 1 | 6169 | good bad | |
PE | phosphatidylethanolamino | 1 | 5899 | good bad | |
PE | pituitary extract | 1 | 5885 | good bad | |
PE | phosphoglyceride fraction | 1 | 5839 | good bad | |
PE | polyethyleneglycol(PEG)-phosphatidylethanolamine | 1 | 5830 | good bad | |
PE | peripheral vein | 1 | 5593 | good bad | |
PE | pasteurization effect | 1 | 5519 | good bad | |
PE | paraffin-embedded | 1 | 5518 | good bad | |
PE | pore's radius | 1 | 5438 | good bad | |
PE | peptide E | 1 | 5390 | good bad | |
PE | pulmonary embolisms | 1 | 5296 | good bad | |
PE | persistent-estrous | 1 | 5260 | good bad | |
PE | polyclonal antibody biotinylated ELISA | 1 | 5255 | good bad | |
PE | placental extract | 1 | 5194 | good bad | |
PE | diacyl-phosphatidylethanolamine | 1 | 5149 | good bad | |
PE | pleiotropic effects | 1 | 5072 | good bad | |
PE | prominent ears | 1 | 5049 | good bad | |
PE | PH are pulmonary thromboemboli | 1 | 4943 | good bad | |
PE | probe-earmold | 1 | 4908 | good bad | |
PE | packed human erythrocytes | 1 | 4780 | good bad | |
PE | polyhedron envelope | 1 | 4742 | good bad | |
PE | perimeter | 1 | 4649 | good bad | |
PE | propionyl esterase | 1 | 4463 | good bad | |
PE | proteolytic enzymes | 1 | 4452 | good bad | |
PE | Proportionate expansion | 1 | 4443 | good bad | |
PE | primary extranodal | 1 | 4393 | good bad | |
PE | phosphatidyl ethanolamines | 1 | 4378 | good bad | |
PE | potential energy | 1 | 4361 | good bad | |
PE | primers in an automated 377 sequencer | 1 | 4213 | good bad | |
PE | parietal endodermal | 1 | 4145 | good bad | |
PE | partial (70%) hepatectomy on phosphatidylethanolamine | 1 | 4114 | good bad | |
PE | Pancreatic extract | 1 | 4089 | good bad | |
PE | pigmented epithelia | 1 | 3982 | good bad | |
PE | patients with IBD using phycoerythrin | 1 | 3934 | good bad | |
PE | polyethylene terephthalate (PET) or polyester | 1 | 3881 | good bad | |
PE | pre-exposed | 1 | 3785 | good bad | |
PE | primary clarifier effluent | 1 | 3749 | good bad | |
PE | physical examination by trained personnel | 1 | 3725 | good bad | |
PE | Proopiomelanocortin (POMC) and proenkephalin | 1 | 3672 | good bad | |
PE | Polyester | 1 | 3626 | good bad | |
PE | yoelii-parasitized erythrocytes | 1 | 3542 | good bad | |
PE | Proportions of phosphatidylethanolamine | 1 | 3542 | good bad | |
PE | presented with phosphatidylethanolamine | 1 | 3463 | good bad | |
PE | pigmented epithelial cells | 1 | 3455 | good bad | |
PE | proestrus | 1 | 3406 | good bad | |
PE | production extract | 1 | 3396 | good bad | |
PE | pure ethanol | 1 | 3354 | good bad | |
PE | principally with phosphatidylethanolamine | 1 | 3301 | good bad | |
PE | EGF-Pseudomonas exotoxin | 1 | 2978 | good bad | |
PE | prostaglandin E-1 | 1 | 2801 | good bad | |
PE | protected environment | 1 | 2691 | good bad | |
PE | pleural empyema | 1 | 2617 | good bad | |
PE | Pseudo Expectation Approach | 1 | 2444 | good bad | |
PE | Phosphorothioate (PS)-capped phosphodiester | 1 | 2417 | good bad | |
PE | pallium externum | 1 | 2158 | good bad | |
PE | phenelzine (PLZ) or of beta-phenylethylamine | 1 | 2138 | good bad | |
PE | polyethers | 1 | 2090 | good bad | |
PE | percentage of platelets binding phycoerythrin | 1 | 1825 | good bad | |
PE | pregnancies complicated by severe preeclampsia | 1 | 1681 | good bad | |
PE | peritoneal exudates | 1 | 1428 | good bad | |
PE | R-phycoerythrin | 1 | 1417 | good bad | |
PE | processing elements | 1 | 1290 | good bad | |
PE | palpation examination | 1 | 1137 | good bad | |
PE | polyethyleneglycol (PEG)-phosphatidylethanolamine | 1 | 1093 | good bad | |
PE | phosphate contents | 1 | 1080 | good bad | |
PE | phase-encoding | 1 | 1057 | good bad | |
PE | predominantly epithelioid | 1 | 1057 | good bad | |
PE | physical education class | 1 | 1049 | good bad | |
PE | permanent environmental effects | 1 | 964 | good bad | |
PE | polychromatic erythroblasts | 1 | 952 | good bad | |
PE | phospholipids phosphatidylethanolamine | 1 | 913 | good bad | |
PE | postembolization | 1 | 910 | good bad | |
PE | protective effect | 1 | 907 | good bad | |
PE | pulmonary oedema | 1 | 900 | good bad | |
PE | paralytic esotropia | 1 | 873 | good bad | |
PE | Pseudomonas exotoxin gene | 1 | 867 | good bad | |
PE | point estimates | 1 | 706 | good bad | |
PE | positive by day 14 postexposure | 1 | 681 | good bad | |
PE | periventricular preoptic nucleus | 1 | 662 | good bad | |
PE | phycocyanin (PC) and phycoerythrin | 1 | 657 | good bad | |
PE | packed erythrocytes | 1 | 643 | good bad | |
PE | position and phosphatidylethanolamine | 1 | 570 | good bad | |
PE | PEG-filgrastim, | 1 | 517 | good bad | |
PE | Plasma-exchange | 1 | 512 | good bad | |
PE | prostate epithelial | 1 | 501 | good bad | |
PE | pathophysiological features of pre-eclampsia | 1 | 479 | good bad | |
PE | Phthalate esters | 1 | 463 | good bad | |
PE | Pseudomonas elastase | 1 | 375 | good bad | |
PE | persistent type-II endoleaks | 1 | 349 | good bad | |
PE | plaque enlargement | 1 | 339 | good bad | |
PE | periphery effect | 1 | 294 | good bad | |
PE | palmitate into phosphatidylethanolamine | 1 | 107 | good bad | |
PE | phosphatidylcholine (PC) (37%) and phosphatidylethanolamine | 1 | 87 | good bad | |
PE | Periapical exudates | 1 | 82 | good bad | |
PE | pemphigus erythematosus | 1 | 76 | good bad | |
PE | permeability coefficients | 1 | 73 | good bad | |
PE | penile enlargement | 1 | 72 | good bad | |
PE | primarily incorporated into phosphatidylethanolamine | 1 | 71 | good bad | |
PE | program evaluation | 1 | 68 | good bad | |
PE | CD4-Pseudomonas exotoxin A | 1 | 68 | good bad | |
PE | mildest--premature ejaculation | 1 | 63 | good bad | |
PE | phospholipid methylation which converts phosphatidylethanolmine | 1 | 63 | good bad | |
PE | propofol on phenylephrine | 1 | 34 | good bad | |
PE | coumarin-phosphatidylethanolamine | 1 | 18 | good bad | |
PE | probe fluo-3 and using R-phycoerythrin | 1 | 14 | good bad | |
PE | phycobiliproteins phycoerythrin | 1 | 13 | good bad | |
PE | plasma exudation | 1 | 13 | good bad | |
PE | possible pathogenetic factor of preeclampsia | 1 | 10 | good bad | |
PE | polyethene | 1 | 10 | good bad | |
PE | production of erythrocytes | 1 | 10 | good bad | |
PE | plasma norepinephrine (PNE) or epinephrine | 1 | 10 | good bad | |
PE | 5-amino-1-pentanol | 1 | 10 | good bad | |
PE | pyroelectric | 1 | 9 | good bad | |
PE | provided they contained phosphatidylethanolamine | 1 | 9 | good bad | |
PE | pregnancy edema | 1 | 9 | good bad | |
PE | pleural exudate | 1 | 9 | good bad | |
PE | pinealectomized | 1 | 8 | good bad | |
PE | 1-palmitoyl-2-stearoyl glycerophosphoethanolamine | 1 | 6 | good bad | |
PE | phenol | 1 | 6 | good bad | |
PE | proliferative endometria | 1 | 5 | good bad | |
PE | potato extracts | 1 | 5 | good bad | |
PE | population equivalent | 1 | 5 | good bad | |
PE | PIH or preeclampsia | 1 | 5 | good bad | |
PE | preparations which contain phosphatidylethanolamine | 1 | 4 | good bad | |
PE | Pseudomonas aeruginosa elastase | 1 | 4 | good bad | |
PE | pre eclamptic | 1 | 4 | good bad | |
PE | Platinum and Etoposide | 1 | 4 | good bad | |
PE | auristatin-phenethylamine | 1 | 4 | good bad | |
PE | pancreatic encephalopathy | 1 | 4 | good bad | |
PE | person equivalent | 1 | 4 | good bad | |
PE | portal circulations | 1 | 4 | good bad | |
PE | parabolic wave equation | 1 | 3 | good bad | |
PE | phosphorous esters | 1 | 3 | good bad | |
PE | proliferative enteropathy | 1 | 3 | good bad | |
PE | Poisson equation | 1 | 3 | good bad | |
PE | probability of exclusion | 1 | 3 | good bad | |
PE | peritoneal effluent | 1 | 3 | good bad | |
PE | phase of the unsaturated dioleoylphosphatidylethanolamine | 1 | 3 | good bad | |
PE | plasmaexchange | 1 | 3 | good bad | |
PE | pigeon erythrocytes | 1 | 2 | good bad | |
PE | phosphatidy glycerols (PG) and phosphatidylethanolamine | 1 | 2 | good bad | |
PE | platinum + epirubicin | 1 | 2 | good bad | |
PE | phosphatidyleth-anolamine | 1 | 2 | good bad | |
PE | perseverative error | 1 | 2 | good bad | |
PE | Proton enhanced | 1 | 2 | good bad | |
PE | proportion of errors | 1 | 2 | good bad | |
PE | pregnancy-induced hypertension (PIH) and preeclampsia | 1 | 2 | good bad | |
PE | 2-di-O-alkyl-glycerophosphoethanolamines | 1 | 2 | good bad | |
PE | polarizable electropole | 1 | 2 | good bad | |
PE | phophatidylethanolamine | 1 | 2 | good bad | |
PE | extravidin-R-phycoerythrin | 1 | 1 | good bad | |
PE | pulmonary endocrine | 1 | 1 | good bad | |
PE | peak-equivalent | 1 | 1 | good bad | |
PE | cis-platin/etoposide | 1 | 1 | good bad | |
PE | presumptive Eschericia coli | 1 | 1 | good bad | |
PE | primarily ethanolamine | 1 | 1 | good bad | |
PE | phospholipid phosphatidylethanolamine | 1 | 1 | good bad | |
PE | properties of phosphatidylethanolamine | 1 | 1 | good bad | |
PE | paraffin embedded | 1 | 1 | good bad | |
PE | Peak enhancement | 1 | 1 | good bad | |
PE | partial epilepsy | 1 | 1 | good bad | |
PE | proportional error | 1 | 1 | good bad | |
PE | phorbol esters | 1 | 0 | good bad | |
PE | particularly phosphatidylcholine (PC) and phosphatidylethanolamine | 1 | 0 | good bad | |
PE | positive polyelectrolyte | 1 | 0 | good bad | |
PE | Parodi endograft | 1 | 0 | good bad | |
PE | patients with suspected pulmonary thromboembolism | 1 | 0 | good bad | |
PE | previous experience comparing cisplatin/etoposide | 1 | 0 | good bad | |
PE | placentome to phenylephrine | 1 | 0 | good bad | |
PE | Phosphatidylinositolmannosides and phosphatidylethanolamine | 1 | 0 | good bad | |
PE | dioleoyl-phosphatidylcholine (PC) and dioleoyl-phosphatidylethanolamine | 1 | -1 | good bad | |
PE | pre-contracted with phenylephrine | 1 | -1 | good bad | |
PE | phosphate of phosphatidylethanolamine | 1 | -1 | good bad | |
PE | plasma glucosylceramide (GlcCer) or phosphatidylethanolamine | 1 | -1 | good bad | |
PE | pinealectomy | 1 | -2 | good bad | |
PE | precontraction with phenylephrine | 1 | -2 | good bad | |
PE | primitive endoderm | 1 | -2 | good bad | |
PE | posterior ectosylvian | 1 | -2 | good bad | |
PE | d-pseudoephedrine | 1 | -2 | good bad |
|
Text2Knowledge ... Yong Huang
2002
|